Animal Cell Therapies, Inc., founded in 2009
Animal Cell Therapies, Inc., is a veterinary biotechnology company founded by a veterinarian to address the needs of an under-served, aging pet population.
As scientists and doctors, pet lovers and pet owners, Animal Cell Therapies, Inc., is devoted to giving animals the best life that science can provide. Millions of people worldwide want to give their pets the long, healthy lives they deserve.
Our mission is simple: to deliver a new frontier of stem cell therapies and make that hope a reality. Man’s best science for man’s best friendTM.
ACT’s mission is to develop and standardize pure and potent high quality stem cell treatments for orthopedic and chronic diseases in animals to:
•Improve the quality of life of pets
•Increase treatment efficacy
•Provide consistent, easily produced, products that can be easily administered in an outpatient setting
With 78 million dogs in the U.S. and a pet population growing twice as fast as the human population, the health and longevity of our pets is more important than ever. The problem is that 80% of dogs over the age of seven dogs suffer from an orthopedic problem.
Animal Cell Therapies, Inc., will deliver innovative cell-based therapies to improve the quality of life of our pets.
Novel Approaches in Veterinary Stem Cell Therapy
Animal Cell Therapies’ main focus is to research stem cell therapeutic behavior and to develop condition-specific stem cell treatments for companion animals that suffer from orthopedic and other chronic disease conditions.
To help us accomplish this challenge, we brought together a group of prominent scientific leaders with expertise in stem cell biology, orthopedics, internal medicine, human and veterinary medicine.
The company follows the FDA’s Center for Veterinary Medicine recommendations for developing stem cell treatments for companion animals.